AMACR (alpha-methylacyl-CoA racemase), a key enzyme involved in fatty-acid metabolism, serves as a well-established diagnostic biomarker that is markedly overexpressed in prostate-cancer epithelium compared with benign glands [34]. This evidence concerns the gene AMACR and prostate cancer.